Companies across North America are increasingly outsourcing activities such as target validation, compound screening, lead optimization, pharmacology, and preclinical research. Collaborations with specialized service providers allow drug developers to access technical expertise, advanced laboratory capabilities, and specialized research platforms without expanding internal infrastructure....